These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


541 related items for PubMed ID: 29143228

  • 21. Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer.
    Singh R, Pochampally R, Watabe K, Lu Z, Mo YY.
    Mol Cancer; 2014 Nov 26; 13():256. PubMed ID: 25428807
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Clinical Relevance of Circulating, Cell-Free and Exosomal microRNAs in Plasma and Serum of Breast Cancer Patients.
    Schwarzenbach H.
    Oncol Res Treat; 2017 Nov 26; 40(7-8):423-429. PubMed ID: 28683441
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Total Blood Exosomes in Breast Cancer: Potential Role in Crucial Steps of Tumorigenesis.
    Konoshenko M, Sagaradze G, Orlova E, Shtam T, Proskura K, Kamyshinsky R, Yunusova N, Alexandrova A, Efimenko A, Tamkovich S.
    Int J Mol Sci; 2020 Oct 05; 21(19):. PubMed ID: 33027894
    [Abstract] [Full Text] [Related]

  • 27. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
    Zhang K, Wang YW, Wang YY, Song Y, Zhu J, Si PC, Ma R.
    Gene; 2017 Jul 01; 619():10-20. PubMed ID: 28359916
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Plasma Exosome-Derived microRNAs as Potential Diagnostic and Prognostic Biomarkers in Brazilian Pancreatic Cancer Patients.
    Marin AM, Mattar SB, Amatuzzi RF, Chammas R, Uno M, Zanette DL, Aoki MN.
    Biomolecules; 2022 May 31; 12(6):. PubMed ID: 35740894
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. miR-15a-5p, A Novel Prognostic Biomarker, Predicting Recurrent Colorectal Adenocarcinoma.
    Kontos CK, Tsiakanikas P, Avgeris M, Papadopoulos IN, Scorilas A.
    Mol Diagn Ther; 2017 Aug 31; 21(4):453-464. PubMed ID: 28405803
    [Abstract] [Full Text] [Related]

  • 32. Exosomal miRNAs from highly metastatic cells can induce metastasis in non-metastatic cells.
    Kia V, Mortazavi Y, Paryan M, Biglari A, Mohammadi-Yeganeh S.
    Life Sci; 2019 Mar 01; 220():162-168. PubMed ID: 30721706
    [Abstract] [Full Text] [Related]

  • 33. Malignant canine mammary epithelial cells shed exosomes containing differentially expressed microRNA that regulate oncogenic networks.
    Fish EJ, Irizarry KJ, DeInnocentes P, Ellis CJ, Prasad N, Moss AG, Curt Bird R.
    BMC Cancer; 2018 Aug 20; 18(1):832. PubMed ID: 30126376
    [Abstract] [Full Text] [Related]

  • 34. Recent Advances in Experimental Models of Breast Cancer Exosome Secretion, Characterization and Function.
    Pelissier Vatter FA, Lucotti S, Zhang H.
    J Mammary Gland Biol Neoplasia; 2020 Dec 20; 25(4):305-317. PubMed ID: 33351162
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Dysregulated microRNA expression profiles in cholangiocarcinoma cell-derived exosomes.
    Kitdumrongthum S, Metheetrairut C, Charoensawan V, Ounjai P, Janpipatkul K, Panvongsa W, Weerachayaphorn J, Piyachaturawat P, Chairoungdua A.
    Life Sci; 2018 Oct 01; 210():65-75. PubMed ID: 30165035
    [Abstract] [Full Text] [Related]

  • 37. Detection of phosphatidylserine-positive exosomes for the diagnosis of early-stage malignancies.
    Sharma R, Huang X, Brekken RA, Schroit AJ.
    Br J Cancer; 2017 Aug 08; 117(4):545-552. PubMed ID: 28641308
    [Abstract] [Full Text] [Related]

  • 38. MiR-17-5p may serve as a novel predictor for breast cancer recurrence.
    Wang Y, Li J, Dai L, Zheng J, Yi Z, Chen L.
    Cancer Biomark; 2018 Aug 08; 22(4):721-726. PubMed ID: 29914008
    [Abstract] [Full Text] [Related]

  • 39. Identification and functional characterization of microRNAs reveal a potential role in gastric cancer progression.
    Li CY, Liang GY, Yao WZ, Sui J, Shen X, Zhang YQ, Peng H, Hong WW, Ye YC, Zhang ZY, Zhang WH, Yin LH, Pu YP.
    Clin Transl Oncol; 2017 Feb 08; 19(2):162-172. PubMed ID: 27173517
    [Abstract] [Full Text] [Related]

  • 40. Serum microRNA expression signatures identified from genome-wide microRNA profiling serve as novel noninvasive biomarkers for diagnosis and recurrence of bladder cancer.
    Jiang X, Du L, Wang L, Li J, Liu Y, Zheng G, Qu A, Zhang X, Pan H, Yang Y, Wang C.
    Int J Cancer; 2015 Feb 15; 136(4):854-62. PubMed ID: 24961907
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 28.